Alligator Bioscience AB Year-end Report January-December 2019

February 12, 2020   |   February 2020 Bond Updates
STOCKHOLM, Feb. 12, 2020 /PRNewswire/ -- "2019 was the year when Alligator entered the clinical phase on a broad front. At the beginning of the year, we had one clinical project and at year-end, the number had increased to four", commented CEO Per Norlén. Significant events October -...

View more at:
Related News
Home| About us | Contact us